BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/13/2021 12:57:54 PM | Browse: 18 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 66486
Country/Territory United Kingdom
Received
2021-03-29 04:41
Peer-Review Started
2021-03-29 04:48
To Make the First Decision
Return for Revision
2021-06-23 23:33
Revised
2021-07-05 20:21
Second Decision
2021-08-23 02:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-08-23 08:20
Articles in Press
2021-08-23 08:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-10-08 16:19
Publish the Manuscript Online
2021-10-13 12:57
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Review
Article Title Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis
Manuscript Source Invited Manuscript
All Author List Francesca Saffioti and Vasileios K Mavroeidis
ORCID
Author(s) ORCID Number
Francesca Saffioti http://orcid.org/0000-0001-7635-9931
Vasileios K Mavroeidis http://orcid.org/0000-0002-8188-3575
Funding Agency and Grant Number
Corresponding Author Vasileios K Mavroeidis, FICS, FRSC, MD, MSc, Surgeon, Department of Surgery, The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London SW3 6JJ, United Kingdom. vasileios.mavroeidis@nhs.net
Key Words Cholangiocarcinoma; Primary sclerosing cholangitis; Liver resection; Liver transplantation; Neoadjuvant therapy; Adjuvant therapy
Core Tip Cholangiocarcinoma (CCA) in primary sclerosing cholangitis (PSC) has become the leading cause of death. Major hepatic resection is commonly not possible in PSC patients to treat CCA, but overwhelming progress with excellent results in the last two decades has established an increasing role of protocolised combination of neoadjuvant chemoradiation and orthotopic liver transplantation. We review in detail, the incidence, as well as aspects of treatment and outcomes according to the different anatomical locations of CCA in PSC, through the viewpoint of historical evolution of treatment paradigms.
Publish Date 2021-10-13 12:57
Citation Saffioti F, Mavroeidis VK. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. World J Gastrointest Oncol 2021; 13(10): 1336-1366
URL https://www.wjgnet.com/1948-5204/full/v13/i10/1336.htm
DOI https://dx.doi.org/10.4251/wjgo.v13.i10.1336
Full Article (PDF) WJGO-13-1336.pdf
Full Article (Word) WJGO-13-1336.docx
Manuscript File 66486_Auto_Edited-JLW (3).docx
Answering Reviewers 66486-Answering reviewers.pdf
Audio Core Tip 66486-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 66486-Conflict-of-interest statement.pdf
Copyright License Agreement 66486-Copyright license agreement.pdf
Peer-review Report 66486-Peer-review(s).pdf
Scientific Misconduct Check 66486-Bing-Wang LL-2.png
Scientific Misconduct Check 66486-Scientific misconduct check.pdf
Scientific Editor Work List 66486-Scientific editor work list.pdf